Simplify Health Care ETF Rating $37.10 0.00 (0.00%) As of 06/12/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Simplify Health Care ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PINK Aggregate RatingModerate Buy 2.68Holdings in PINK have an aggregate rating of Moderate Buy based on 494 analyst ratings issued in the past year covering 25 companies (92.1% of the portfolio).PINK Aggregate Price Target$37.10High Prediction$37.10Average Prediction$37.10Low Prediction$37.10Holdings in PINK have an aggregate price target of $37.10 and a range of $37.10 to $37.10 covering 25 companies (92.1% of the portfolio).PINK Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Simplify Health Care ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 PINK Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings11.41%PCTPureCycle Technologies$8.882.5361 of 5 stars2.50$11.00 23.9%4Analyst ForecastGap Up7.30%UTHRUnited Therapeutics$545.964.2269 of 5 stars2.85$619.42 13.5%13Insider Trade6.21%NVONovo Nordisk A/S$43.90+0.0%4.2584 of 5 stars2.13$65.56 49.3%23Trending NewsAnalyst Revision5.59%LLYEli Lilly and Company$1,137.01+0.4%4.1125 of 5 stars2.87$1,227.74 8.0%30Trending NewsAnalyst RevisionGap Up5.03%JNJJohnson & Johnson$240.57-0.1%4.417 of 5 stars2.74$253.04 5.2%27Trending NewsInsider Trade4.64%JAZZJazz Pharmaceuticals$230.563.3405 of 5 stars2.84$246.06 6.7%19Trending NewsInsider Trade4.58%UNHUnitedHealth Group$408.340.0%4.1992 of 5 stars2.78$407.17 -0.3%27Trending NewsOptions Volume4.10%ABBVAbbVie$227.54-0.1%4.4846 of 5 stars2.88$253.43 11.4%25Trending News4.08%ALGNAlign Technology$174.843.769 of 5 stars2.71$205.85 17.7%14Analyst Downgrade3.83%TXG10x Genomics$28.841.9131 of 5 stars2.20$23.17 -19.7%15Gap Up3.77%BHVNBiohaven$11.34+0.6%2.8482 of 5 stars2.71$22.27 96.3%173.72%WRBYWarby Parker$26.32-0.5%3.427 of 5 stars2.64$29.50 12.1%14Insider Trade3.20%TMOThermo Fisher Scientific$468.80-0.1%4.8983 of 5 stars2.88$608.95 29.9%25Positive NewsAnalyst Revision3.07%GILDGilead Sciences$125.594.9211 of 5 stars2.86$156.93 25.0%29Trending NewsAnalyst Revision2.90%ELVElevance Health$403.74-0.1%4.3566 of 5 stars2.61$416.11 3.1%23News CoveragePositive News2.63%BNTCBenitec Biopharma$11.181.7243 of 5 stars2.56$27.00 141.5%9Analyst Downgrade2.62%REGNRegeneron Pharmaceuticals$612.144.8595 of 5 stars2.70$792.65 29.5%27Positive News2.23%DHRDanaher$179.95-0.1%4.715 of 5 stars2.84$233.61 29.8%25Trending News2.08%AMGNAmgen$355.203.8196 of 5 stars2.48$354.12 -0.3%31Trending NewsAnalyst Forecast1.86%CVSCVS Health$101.87-0.1%4.1098 of 5 stars2.85$100.68 -1.2%26Trending NewsAnalyst Downgrade1.77%AZNAstrazeneca$178.79+0.0%4.6001 of 5 stars2.85$205.33 14.8%13Analyst RevisionGap Up1.55%CAHCardinal Health$223.760.0%4.1011 of 5 stars2.94$246.93 10.4%17Analyst Downgrade1.32%VRTXVertex Pharmaceuticals$444.920.0%4.6416 of 5 stars2.88$555.91 24.9%25Trending News1.31%EYPTEyepoint Pharmaceuticals$13.032.7625 of 5 stars3.00$31.80 144.1%7Positive News1.28%ESTAEstablishment Labs$82.141.5569 of 5 stars2.67$87.14 6.1%9Gap Up This page (NYSEARCA:PINK) was last updated on 6/15/2026 by MarketBeat.com Staff. From Our PartnersThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredIs SpaceX really worth 1.78 Trillion?With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...InvestPub | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredSpaceX is chump change compared to Elon’s $20T ‘iPhone’Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Simplify Health Care ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Simplify Health Care ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
